Marc Gillinov Net Worth 2026 - Estimated Wealth & Sources

As of August 12, 2026, Marc Gillinov's estimated net worth is approximately $6,000,000, with a plausible range of $3,000,000 to $12,000,000. That midpoint is anchored by one unusually solid data point: his 2024 reportable compensation from Cleveland Clinic, documented at $2,141,240 in the institution's publicly filed Form 990. Layered on top of that institutional salary are consulting fees, medical device royalties and equity interests, book royalties from a widely circulated trade title, and speaking income at major cardiothoracic surgery conferences. The range is wide because the richest parts of his income, including private equity stakes in medical device companies and undisclosed royalty arrangements, are not broken out in any public filing. More on the methodology below.

At-a-Glance Numbers

Career Overview and How He Built His Income

Marc Alan Gillinov, MD is the Chair of the Department of Thoracic and Cardiovascular Surgery in the Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute at Cleveland Clinic, one of the highest-ranked cardiac surgery programs in the United States. He earned his undergraduate degree at Yale and his medical degree at Johns Hopkins School of Medicine, two institutions that still carry real weight in physician salary negotiations. He joined Cleveland Clinic staff in 1997, which means by 2026 he has nearly three decades of seniority at an institution well known for paying its top surgeons at the high end of the specialty range.

The chair title matters financially. Department chairs at major academic medical centers typically earn meaningfully above the median for their specialty, both because they carry administrative responsibilities and because they are recruited and retained with competitive packages. The STS Cardiothoracic Surgeon Compensation Survey and aggregated MGMA benchmarks consistently show total compensation for high-volume cardiac surgeons and department leaders in the high six figures to low seven figures range, and Gillinov's Form 990 figure of $2,141,240 sits right in that top-tier bracket.

Career Timeline

Primary Income Streams

• Institutional salary and bonuses at Cleveland Clinic: the dominant, documented income stream at over $2.1 million annually per the 2024 Form 990
• Consulting and advisory fees: Cleveland Clinic's staff disclosure page notes fees of $5,000 or more per year from named companies including ClearFlow, Edwards Lifesciences, Baxter, and others
• Speaking honoraria: conference programs from AATS and STS list him as a keynote-level presenter; industry benchmarks put honoraria at $2,000–$25,000 per engagement for specialists at his profile
• Book royalties: Heart 411, co-authored with Steven Nissen, MD, was published in 2012 by Harmony (a Crown/Penguin Random House imprint); typical trade royalty rates of 7.5–12.5% of list price apply, with meaningful but diminishing annual income over the book's lifecycle
• Medical device royalties and equity: the AtriClip Gillinov-Cosgrove left atrial appendage device carries his name in AtriCure product literature and regulatory filings, suggesting a royalty or naming arrangement; 2025–2026 author disclosures in peer-reviewed journals explicitly list an equity interest in ClearFlow (Clear Catheter Systems)
• Patents and technology commercialization: USPTO and patent-index records list Gillinov as a co-inventor on at least one surgical device patent (pre-sized prosthetic chordae system), with Cleveland Clinic likely holding the institutional patent rights; any inventor-share distributions depend on the clinic's internal policy
• Investment income: accumulated savings from nearly three decades of high-level compensation reasonably include market-based investment portfolios, though details are not publicly disclosed

Known Assets and Liabilities

This is the section where transparency requires a somewhat unsatisfying answer: there is limited public record of Marc Gillinov's personal assets. No SEC insider filings (Forms 3, 4, or 5) were found on EDGAR under his name as of August 12, 2026, which suggests he does not hold reportable equity stakes in any publicly traded company above SEC disclosure thresholds, or those holdings have not surfaced through the standard EDGAR search. His equity interest in ClearFlow is documented through author disclosures in published research, but ClearFlow (Clear Catheter Systems) is a private company, so no valuation or share-count data is publicly available. A PubMed-listed article titled 'Robotic mitral valve surgery: current limitations and future directions' includes an author disclosure explicitly listing 'Equity interest (ClearFlow)' A PubMed-listed article titled 'Robotic mitral valve surgery: current limitations and future directions' includes an author disclosure explicitly listing 'Equity interest (ClearFlow)'..

No property records under his name were identified in the publicly accessible searches conducted for this estimate. That does not mean he does not own real estate; it means county-level deed records and aggregated property databases did not return confirmed results linking to him specifically. Cleveland Clinic's Form 990 disclosure represents the most concrete, verifiable financial figure in the public record.

How We Built the Estimate: Step-by-Step

Estimating the net worth of a physician who is not a public company executive requires a slightly different approach than reading an SEC filing. Here is exactly how the $6 million midpoint was derived, so you can weight it appropriately.

1. Start with the anchor: The Cleveland Clinic Form 990 for fiscal year 2024 reports Gillinov's compensation as $2,141,240. This is the single most reliable number in the entire estimate and it drives everything else.
2. Project backward: Gillinov has been at Cleveland Clinic since 1997. He almost certainly did not earn $2 million a year for that entire period, but departmental chair-level compensation at major academic centers in cardiac surgery has been in the high six to low seven figures for at least the past decade. A conservative assumption of an average of $1.2–1.5 million per year over the most recent 10-year period (2014–2024) yields cumulative gross earnings of roughly $12–15 million before tax.
3. Apply a realistic net savings rate: High-earning physicians in academic medicine typically face effective federal plus state tax rates of 40–45% at this income level. After taxes, living expenses, and retirement contributions, a conservative net savings/accumulation rate of 25–30% of gross income is a reasonable modeling assumption. Applied to the 10-year gross estimate, that produces accumulated savings and investment assets in the range of $3–4.5 million from institutional salary alone.
4. Add consulting and speaking income: Cleveland Clinic's disclosure page and COI statements in published research confirm fee relationships with at least six named companies. Using the industry benchmark range of $2,000–$25,000 per engagement and assuming modest frequency (5–20 paid engagements per year), this income stream adds an estimated $100,000–$400,000 annually. Over five to ten years, cumulative post-tax consulting income contributes an estimated $300,000–$1,500,000 to net worth.
5. Add book royalties (Heart 411): Trade books on health topics by physician authors at major publishers typically earn advances in the $50,000–$200,000 range for co-authors, plus ongoing royalties. Heart 411 was published in 2012 and has had 14 years of sales; it is reasonable to model cumulative royalty income in the $50,000–$150,000 range over its lifetime, with the bulk earned in the early years after publication.
6. Add device equity and royalties (ClearFlow / AtriClip): This is the most uncertain line. Author disclosures confirm an equity interest in ClearFlow. AtriCure's product literature names the AtriClip Gillinov-Cosgrove device. Without private company valuations or disclosed royalty rates, a conservative range of $250,000–$2,000,000+ is modeled based on stage and scale of the relevant companies and typical inventor-share structures in medical device commercialization.
7. Sum the components: Combining accumulated salary savings ($3–4.5M), consulting income ($0.3–1.5M), book royalties ($0.05–0.15M), and device-related income ($0.25–2M) yields a total range of roughly $3.6–8.15 million in identifiable accumulated wealth. Rounding, and accounting for the possibility of real estate equity or other assets not in the public record, produces the stated range of $3,000,000 to $12,000,000 with a midpoint of $6,000,000.
8. No liabilities were added or subtracted: No public mortgage records, personal loans, or other liabilities were identified. The estimate is treated as a net figure, though undisclosed liabilities could reduce it.

What the Data Shows and Where It Gets Fuzzy

The Cleveland Clinic Form 990 compensation figure is the gold standard here: it is a public legal document filed with the IRS and available for public inspection. Everything else involves assumptions. The consulting and speaking income estimates are grounded in verified disclosure statements that confirm the relationships exist, and industry benchmark ranges that approximate what those relationships are typically worth, but the actual dollar amounts paid are not in the public record. The device equity estimate is even softer: ClearFlow is private, and while the equity interest is confirmed in peer-reviewed disclosures, the company's valuation, Gillinov's ownership percentage, and whether any liquidity events have occurred are all unknown.

The estimate also uses a backward-projection methodology that assumes consistent high earnings over time, which is an assumption rather than a documented fact. Physicians' incomes can vary significantly year to year based on procedural volume, institutional restructuring, and changes in consulting relationships. It is entirely plausible that net worth is lower if tax rates were higher than modeled, living expenses were substantial, or consulting relationships are relatively recent. It is also plausible that net worth is higher if real estate holdings exist and have appreciated, or if ClearFlow or another device investment has produced a meaningful return.

What We Did Not Find

• No SEC Forms 3, 4, or 5 under his name on EDGAR as of August 12, 2026 (no reportable public-company equity positions identified)
• No confirmed real estate records or property deeds linked to his name in publicly accessible databases
• No detailed royalty or licensing agreement terms for the AtriClip Gillinov-Cosgrove device or prosthetic chordae patents
• No valuation or capitalization data for ClearFlow (Clear Catheter Systems) as a private company
• No historical W-2 or prior-year Form 990 compensation entries going back to the 1990s or 2000s
• No disclosed investment portfolio, brokerage account, or retirement fund balances

How Gillinov Compares to Peers

Context helps. Gillinov is not a hedge fund billionaire or a technology entrepreneur, and his net worth should be evaluated against the realistic financial arc of a top-tier academic cardiac surgeon who has built secondary income through intellectual contributions (a book, patents, device development) alongside a primary clinical career. Here is how he stacks up against some relevant benchmarks and profiles.

The comparison makes clear that Gillinov's wealth profile is what you would expect for an elite academic surgeon who has monetized his expertise thoughtfully but has not made a dramatic private equity or tech bet. The device commercialization angle (ClearFlow equity, AtriClip naming) is the most interesting variable: if ClearFlow were acquired by a major medtech company, the equity interest noted in his disclosures could move the needle substantially. As of today there is no public indication that has happened.

Who Else Might You Be Looking For? Disambiguation

The name 'Marc Gillinov' is fairly distinctive, but searches for variations of the name 'Marc G' or even misspellings can land you in the wrong place. For a related comparison, see the profile on gillie and marc net worth. If you meant a different individual, see the Marc Ganis net worth profile for that separate person's financial summary. If you were looking for the cardiologist Marc Gorlin instead, see the Marc Gorlin net worth profile for that individual's estimated finances. Below is a quick reference for the other Marc profiles covered on this site, in case one of them is actually who you were looking for. If you were searching for 'marc gilpin net worth', note that Marc Gilpin is a different individual and that query corresponds to a separate profile. If you meant the art dealer Marc Glimcher, see the Marc Glimcher net worth profile for that individual's financial summary. If you were looking for the profile of a different Marc, see the Marc Ganzi net worth profile for that individual's estimated assets and income. If you meant a different Marc, such as entrepreneur Marc Glassman, see our separate profile on Marc Glassman net worth for that individual's financial estimate.

• Marc Glassman: founder of Marc's discount retail stores in Ohio, a regional retail entrepreneur whose wealth profile is rooted in consumer retail business ownership rather than medicine
• Marc Ganzi: real estate and digital infrastructure investor, former co-CEO of DigitalBridge, with an estimated net worth substantially larger than Gillinov's and derived from private equity carried interest
• Marc Gorlin: technology and fintech entrepreneur, founder of Kabbage and other ventures; wealth driven by startup exits and venture-backed company outcomes
• Marc Glimcher: president and CEO of Pace Gallery, one of the world's leading contemporary art galleries; wealth tied to the art market, gallery ownership, and the Glimcher family legacy
• Marc Ganis: sports business consultant and president of Sportscorp Ltd., with deep ties to NFL franchise transactions; a different industry and wealth profile entirely
• Gillie and Marc: the British street art duo (Gillie Schattner and Marc Schattner), known for 'Rabbitwoman and Dogman' characters; their wealth estimation involves art sales, commissions, and global public installations
• Marc Gilpin: actor known for child roles in the late 1970s and early 1980s, most recognizable from Jaws 2; a very different career arc and wealth profile from the cardiac surgeon

Marc Gillinov, the cardiac surgeon and subject of this article, is the only one of these individuals associated with Cleveland Clinic, cardiothoracic surgery, or the medical device industry. See Marc Alan Gillinov, MD, AMA Find a Doctor for an official directory entry listing him at the Cleveland Clinic Main Campus Marc Alan Gillinov, MD — AMA Find a Doctor. If your search brought you here and the description above does not match who you were looking for, one of those sibling profiles is likely the right destination.

A Note on How This Estimate Will Age

Net worth estimates for private-income individuals like academic physicians are snapshots, not ledgers. This estimate was built on August 12, 2026, using the most recent publicly available Form 990 data (reporting period through 2024), current COI disclosures in published research, and industry benchmarks available at that date. Three things could materially change it: a new Form 990 filing showing a significant change in compensation, a public announcement of a ClearFlow or related company acquisition or IPO, or the emergence of any real estate or investment records in accessible public databases. If and when those data points surface, the estimate and its range will be updated accordingly.